42 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
6-K
EX-10.2
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
6-K
EX-10.1
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.2
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.3
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
ahlaoc5onkzt8071v
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-10.1
b6q7oe
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-10.3
tz16ww6p7ynlde040k
28 May 20
Current report (foreign)
11:56am
6-K
EX-10.2
u7k20oo
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.4
gfrqnb0i
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
6cweyg0ol
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.1
f30pxcks 5nia67my
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.1
9ima9oypw4kk
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.4
pxvc0p
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.2
9izd3qnv f3yegj5
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.3
d2t 7r9b44qk44
31 Jul 17
Current report (foreign)
12:00am
6-K
EX-10.1
so617 tv5m0n01daa7
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
6-K/A
EX-10.1
9uu0hb8t 350
25 Feb 13
Current report (foreign) (amended)
12:00am
F-1
EX-10.2
pzoee il6ar81kridw
24 Sep 10
Registration statement (foreign)
12:00am
F-1
EX-10.16
t2lfru3cg2kmol2
24 Sep 10
Registration statement (foreign)
12:00am